McAdam LLC’s Rockwell Medical RMTI Stock Holding History

McAdam LLC’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10	Closed	-$4K	–	479
2018 Q3	$4K	Hold	10	–	–	﹤0.01%	443
2018 Q2	$5K	Buy	+10	New	+$6K	﹤0.01%	400

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

McAdam LLC's RMTI Position: Q4 2018 in Review

McAdam LLC sold out of Rockwell Medical (RMTI) in Q4 2018, closing a stake of 10 shares — an estimated $4K sold.

McAdam LLC first reported a position in RMTI in Q2 2018 and held it in 2 quarters. The position peaked at $5K in Q2 2018. 86 funds tracked by Wall St. Rank hold RMTI as of Q4 2018.

McAdam LLC reported no remaining Rockwell Medical position as of Q4 2018 after selling out during the quarter.
McAdam LLC sold 10 Rockwell Medical shares in Q4 2018, an estimated $4K.
McAdam LLC first reported a position in Rockwell Medical in Q2 2018 and held it in 2 quarters.
McAdam LLC's Rockwell Medical position peaked at $5K in Q2 2018.
86 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2018.

Based on McAdam LLC's 13F filing for Q4 2018, filed 30 Jan 2019.